Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

rogress in the pivotal phase 3 program for naproxcinod

NicOx is developing naproxcinod in phase 3 clinical studies, which are designed to demonstrate that it is safe, well tolerated and effective for treating the signs and symptoms of osteoarthritis, in addition to having no detrimental effect on blood pressure, in contrast to existing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

The phase 3 efficacy program consists of 3 pivotal studies, which are being conducted for regulatory submissions in the U.S. and Europe:

-- The 301 study was conducted in patients with osteoarthritis of the knee

and has provided successful efficacy and blood pressure results which

were presented at the American College of Rheumatology (ACR) in

November 2007. A 52-week open-label safety extension of this study has

now been completed and data are currently being analyzed

-- The 302 study started enrolling patients with osteoarthritis of the

knee in the U.S. in April 2007 and the enrollment of 1020 patients was

successfully completed in December 2007. 26-week efficacy and safety

results are anticipated in the third quarter of 2008

-- The 303 study was initiated in June 2007 in the U.S. and Europe, in

patients with osteoarthritis of the hip. This study is expected to

complete enrollment in the second quarter of 2008 and 13-week efficacy

and safety results are anticipated in 4Q'08

As in the 301 study, patients in the ongoing 302 and 303 studies are undergoing controlled, standardized Office Blood Pressure Measurements (OBPM) at each visit to the treatment center. Following the completion of the phase 3 program, NicOx plans to perform a predefined statistical analysis on the pooled OBPM data from the phase 3 studies, which should be complete in the fourth quarter of 2008. NicOx projects the submission of a New Drug Application (NDA) for naproxcinod to the U
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) has announced the addition of the ... - 2019)" report to their offering. Currently, ... . This is followed by UK and ... are the fastest growing segments. The ... basis of Product (Film Screen, Digital, 3D, Analog Systems, Biopsy ...
(Date:6/2/2015)... June 2, 2015 The ... segments the concerned market with analysis and forecast ... million in 2014, and is estimated to reach ... 19.3% from 2014 to 2019. Browse ... Market for an analysis of industry trends and ...
(Date:6/2/2015)... June 2, 2015 Intarcia Therapeutics, Inc. ... million from its recently announced synthetic royalty / equity ... million. Investors have purchased Convertible Limited Recourse Notes from ... to 2.0% of any future global net sales of ... paid. Investors also have the option, commencing upon U.S. ...
Breaking Medicine Technology:Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
... June 6, 2011 Bayer HealthCare Pharmaceuticals Inc. today ... in SYM ptomatic P rostate CA ... is exclusively licensed from Algeta ASA, in patients with ... primary endpoint by significantly improving overall survival.  Based on ...
... Executive Director of USA Swimming, was named this year,s ... in conjunction with the Wound, Ostomy and Continence Nurses ...  The Great Comebacks® Program, which provides support for people ... surgery, annually honors outstanding individuals who are inspiring others ...
Cached Medicine Technology:Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 2Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 3Great Comebacks® Program Recognizes National Award Winners 2Great Comebacks® Program Recognizes National Award Winners 3Great Comebacks® Program Recognizes National Award Winners 4Great Comebacks® Program Recognizes National Award Winners 5
(Date:6/2/2015)... Food Lion will continue its support of military ... Griller” events, starting June 4 through July 3 in ... will raise funds for Hope For The Warriors®, a ... restoring the family unit, and restoring hope for our ... these events, Food Lion customers will have several options ...
(Date:6/2/2015)... 2015 On Wednesday, May 27, 2015, professional ... a top speed of 207.9 mph. In the process, ... break the 200 mph mark. Jay Leno was on ... episode of Jay Leno’s Garage, which will air on CNBC ... 8.5 mile high speed oval at the Continental Tire Proving ...
(Date:6/2/2015)... The 3TVPhoenix contest, conducted in partnership with Arizona Central Credit ... Morning Arizona program for a code word that then had ... , Lisa Allen of Scottsdale was chosen at random from ... monthly $1,000 prize to her mortgage payments for the next ... and gratitude at winning, indicating that the help with her ...
(Date:6/2/2015)... York, NY (PRWEB) June 02, 2015 ... Profemur hip replacement lawsuit ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is ... County. According to court documents, opening statements were ... asserting that laser etchings on the Profemur hip ... fracture, causing it to snap just three years ...
(Date:6/2/2015)... Did you wish Ryder Weise a happy sixth birthday today? ... asking for presents, but instead a donation to the ... DC Walk. , Ryder was diagnosed with HHT in December ... to sudden and extreme bleeding throughout the body. Though ... old in the form of daily nosebleeds, fatigue and shortness ...
Breaking Medicine News(10 mins):Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2
... the observation that multiple infectious disease strains can coexist. ... The American Naturalist//, where Ken Eames and Matt Keeling ... a mathematical model, the coexistence of multiple strains of ... interaction, which is abetted by monogamous behavior in the ...
... to overdose happens to be opioid painkillers which are ... , ,According to the researchers, powerful opioid drugs ... by Doctors, with a motive to realizing better results ... runs parallel with an increase in deaths due to ...
... International today completed the Phase I clinical trial ... ,The project, which is being done in ... the Program for Appropriate Technology in Health (PATH), ... eliminating epidemic meningitis in sub-Saharan Africa., ,Vaccine ...
... sector undertakings and autonomous bodies will give first preference ... for purchasing 102 medicines for a period of five ... Cabinet, which met here today, the first preference will ... subsidiaries by state governments in their purchases which are ...
... of a single ,family. The disease causes severe anxiety// and ... certain behaviors. It is estimated that close relatives of OCD ... ,Now, new research is shedding new light on ... pattern. And while no one gene "causes" OCD, the research ...
... considering becoming pregnant could prevent preeclampsia if they started ... following it up// during the first three months of ... blood pressure shoots up dangerously and could prove lethal ... of Pittsburgh say that this condition could be avoided ...
Cached Medicine News:Health News:Obsessive-Compulsive Disorder Is Familial 2Health News:Obsessive-Compulsive Disorder Is Familial 3Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 2Health News:Using Multivitamins Before And After Conception Averts Preeclampsia 3
... Smith & Nephew ECTRA II systems permit ... carpal tunnel ligament endoscopically, allowing access via ... while minimizing endoscopic lens fogging with good ... complete visualization and control. ECTRA knives permit ...
... ECTRA II systems permit the surgeon to ... endoscopically, allowing access via two portals for ... lens fogging with good air flow. ECTRA ... control. ECTRA knives permit the surgeon to ...
... AZTEC Shoulder Holder is used for positioning ... lateral position. The shoulder holder is adjustable ... all arm positions and sizes. The MITT ... patients arm in the shoulder holder during ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: